Insulin receptors in virus-induced diabetes mellitus in mice

Insights

Encephalomyocarditis virus infection in mice impairs glucose metabolism by reducing insulin receptors on liver cells. This viral-induced diabetes is linked to decreased insulin receptor number and affinity.

Area of Science:

  • Virology
  • Immunology
  • Metabolic Diseases

Background:

  • Encephalomyocarditis virus (EMCV) is known to cause various diseases in mammals.
  • Viral infections can trigger metabolic dysfunctions, including alterations in glucose homeostasis.
  • Insulin resistance is a key factor in the development of diabetes mellitus.

Purpose of the Study:

  • To investigate the impact of EMCV infection on insulin receptor dynamics in mice.
  • To determine the relationship between viral load, glucose metabolism, and insulin receptor expression.
  • To elucidate the role of insulin receptor alterations in virus-induced diabetes.

Main Methods:

  • DBA/2 mice were infected with the M variant of EMCV.
  • Quantitative estimations of insulin receptors on liver cell membranes were performed.
  • Fasting plasma insulin concentration and 125-I insulin binding to receptors were measured.
  • Changes in receptor number and affinity were assessed over time.

Main Results:

  • EMCV infection caused impaired glucose metabolism starting on day 3, lasting for 5 months.
  • Fasting plasma insulin levels decreased significantly by day 14.
  • Specific binding of 125-I insulin to liver cell membrane receptors decreased significantly by day 3.
  • Insulin receptor number declined by day 1, significantly by day 3, and normalized by day 7.
  • Reduced receptor affinity was observed in infected mice, with greater impact in males.

Conclusions:

  • Alterations in insulin receptors are a significant factor in the initial impairment of glucose metabolism during EMCV infection.
  • These findings suggest a mechanism for virus-induced diabetes involving direct effects on insulin signaling pathways.
  • The study highlights the potential for viral agents to induce metabolic disorders resembling type 2 diabetes.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...